Pricing Log in Create free account

Novogen Limited (KZIA) vs Tiziana Life Sciences Ltd (TLSA)

Novogen Limited and Tiziana Life Sciences Ltd are both Biotechnology companies. Novogen Limited and Tiziana Life Sciences Ltd are of similar size ($80.0M and $79.6M). Across the 6 metrics below, Novogen Limited leads on 3 and Tiziana Life Sciences Ltd on 3.

Valuation

Metric KZIA TLSA Biotechnology median
P/E n/m n/m 10.60
P/S — — 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 1.46 0.04 0.66
EV/Sales n/m n/m 9.02
Earnings yield (2.99%) (74.83%) (32.88%)
Free cash flow yield 0.00% 0.00% (23.13%)

Profitability

Metric KZIA TLSA Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin — — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (51.96%)
Return on assets 0.00% 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KZIA TLSA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 63.24% (45.45%) 29.88%
Revenue growth, 5-year CAGR 11.56% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KZIA TLSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.87 0.76 4.97
Net debt to EBITDA 0.30 0.19 1.01

Dividend

Metric KZIA TLSA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KZIA TLSA Biotechnology median
Market cap 80.01m 79.60m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack